#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: postmenopausal
The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Higher cardiorespiratory fitness may be protective against breast cancer in postmenopausal women
1. In this prospective cohort study, higher cardiorespiratory fitness (CRF) was associated with a substantially lower risk of breast cancer ...
Wellness Check: Exercise
Higher cardiorespiratory fitness may be protective against breast cancer in postmenopausal women 1. In this prospective cohort study, higher cardiorespiratory ...
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...
Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...
#VisualAbstract: Adjuvant ibandronate does not improve survival in postmenopausal patients with ER⁺ breast cancer
Click to read this study in the Journal of Clinical Oncology.
Ribociclib plus letrozole provides greater overall survival benefit advanced breast cancer
1. Ribociclib plus letrozole provides significant overall survival benefit as compared to letrozole alone in patients with advanced breast cancer. ...
Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms
1. A randomized controlled trial of 85 participants found no significant difference in vaginal symptom severity after 12 months between ...
Two-year anastrozole treatment beneficial for disease-free survival in postmenopausal breast cancer
1. A five-year extension of anastrozole treatment was shown not to provide additional benefit compared to a two-year extension in ...